CN104489849B - 一种含有维生素调节剂的固体饮品 - Google Patents
一种含有维生素调节剂的固体饮品 Download PDFInfo
- Publication number
- CN104489849B CN104489849B CN201510010749.9A CN201510010749A CN104489849B CN 104489849 B CN104489849 B CN 104489849B CN 201510010749 A CN201510010749 A CN 201510010749A CN 104489849 B CN104489849 B CN 104489849B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- parts
- solid beverage
- regulator
- beverage containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 17
- 239000007787 solid Substances 0.000 title claims abstract description 14
- 229940088594 vitamin Drugs 0.000 title claims abstract description 12
- 229930003231 vitamin Natural products 0.000 title claims abstract description 12
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 12
- 239000011782 vitamin Substances 0.000 title claims abstract description 12
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 39
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 31
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 30
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 28
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 22
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 18
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 18
- 239000011718 vitamin C Substances 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 17
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 16
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 16
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 16
- 239000011710 vitamin D Substances 0.000 claims abstract description 16
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 16
- 229940046008 vitamin d Drugs 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 15
- 239000011709 vitamin E Substances 0.000 claims abstract description 15
- 229940046009 vitamin E Drugs 0.000 claims abstract description 15
- 229960003080 taurine Drugs 0.000 claims abstract description 14
- NFFJLMKHRCXLJO-UHFFFAOYSA-L magnesium;2-aminobutanedioate Chemical compound [Mg+2].[O-]C(=O)C(N)CC([O-])=O NFFJLMKHRCXLJO-UHFFFAOYSA-L 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 11
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 11
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 11
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 9
- 229930195725 Mannitol Natural products 0.000 claims abstract description 9
- 239000008101 lactose Substances 0.000 claims abstract description 9
- 239000000594 mannitol Substances 0.000 claims abstract description 9
- 235000010355 mannitol Nutrition 0.000 claims abstract description 9
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000011975 tartaric acid Substances 0.000 claims abstract description 8
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 8
- 108010011485 Aspartame Proteins 0.000 claims abstract description 7
- 239000000605 aspartame Substances 0.000 claims abstract description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 7
- 235000010357 aspartame Nutrition 0.000 claims abstract description 7
- 229960003438 aspartame Drugs 0.000 claims abstract description 7
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- WJEIYVAPNMUNIU-UHFFFAOYSA-N [Na].OC(O)=O Chemical compound [Na].OC(O)=O WJEIYVAPNMUNIU-UHFFFAOYSA-N 0.000 claims 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract description 17
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract description 6
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract description 2
- 235000020510 functional beverage Nutrition 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 229960004106 citric acid Drugs 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 229960004756 ethanol Drugs 0.000 abstract 1
- 229960001367 tartaric acid Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000002253 acid Substances 0.000 description 9
- 239000003518 caustics Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- 229940091250 magnesium supplement Drugs 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000001201 calcium accumulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000007514 neuronal growth Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明属于固体饮品技术领域，具体公开了一种含有维生素调节剂的固体饮品，原料包括以下物质：维生素C、维生素B6、维生素D、维生素E、柠檬酸、酒石酸、门冬氨酸镁、牛磺酸、碳酸钠、碳酸氢钠、乳糖、甘露醇、甜橙粉、阿斯巴甜、聚乙二醇6000、乙醇、甜味剂。本发明固体饮品能够快速补充能量、增强抵抗力，是一种用于调节人体机能的功能性饮品制剂；适合运动型人群饮用。
Description
技术领域
本发明涉及固体饮品技术领域。
背景技术
伴随着社会经济活动的日益复杂，生活方式更趋于多样化，人们运动的时间与机会越来越少，由于缺乏体育锻炼而带来的越来越严重的各种问题，如肥胖、高血压、失眠、亚健康等，已经引起人们的重视，因此越来越多的人积极的参加到体育锻炼中。但是由于社会生活节奏快，特别是城市生活压力大，都市运动人群往往参与体育运动时带有精神疲劳，参与体育运动的时间有限，且活动量大，带来诸如抽筋、身体疲劳、乏力等问题，往往不能快速恢复，影响运动后正常的工作和休息。
维生素C是一种水溶性维生素，有研究证实，人脑是人体含维生素C最多的地方，其在人体内的作用主要有以下几点： 一是参与羟化反应，促进胶原合成，维生素C缺乏时，胶原合成障碍，从而导致坏血病；维生素C能提升混合功能氧化酶的活性，增强药物或毒物的解毒（羟化）过程。 二是具有还原作用，维生素C在体内可作为供氢体，又可作为受氢体，在体内氧化还原过程中发挥重要作用，可以促进抗体形成，高浓度的维生素C有助于食物蛋白质中的胱氨酸还原为半胱氨酸，进而合成抗体；促进铁的吸收，维生素C能使难以吸收的三价铁还原为易于吸收的二价铁，从而促进了铁的吸收。此外，还能使亚铁络合酶等的巯基处于活性状态，以便有效地发挥作用。
镁元素是一种重要的微量元素,镁补充改善心肌代谢,抑制钙积累和心肌细胞死亡,它可以提高血管张力,降低外周血管阻力,减少心律失常,改善脂质代谢。同时它还可激活人体内325个酶系统，参与各种能量的代谢活动，是人体一切生长过程，包括骨、细胞、核糖核酸、脱氧核糖核酸以及各种生物膜形成的重要物质，镁在细胞能源生产中扮演着关键角色，与人体必需的能量物质——ATP(三磷酸腺苷)密切相关，因此缺乏镁可能会使你感到疲倦和低能量。镁元素与肌肉痉挛发生相关联，补充镁元素可以有助于肌肉的恢复。
发明内容
本发明要解决的技术问题是提供一种含有维生素调节剂的饮品组合物，本发明饮品组合物能够补充能量、增强抵抗力，具有调节人体机能的功能，其产品感官评判佳，适合运动型人群饮用。
为解决上述技术问题，本发明所采取的技术方案是：一种含有维生素调节剂的固体饮品，其特征在于：原料按重量份包括以下物质：维生素C 0.01～1.5份、维生素B6 0.01～0.5份、维生素D 0.01～0.5份、维生素E 0.01～0.5份、门冬氨酸镁0.01～0.5份、柠檬酸0.01～3.3份、牛磺酸0.01～2份、酒石酸0～22份、碳酸钠0～2.2份、碳酸氢钠0～20份、乳糖0～41份、甘露醇0～41份、聚乙二醇6000含量0～3份、乙醇0～3份、甜味剂0～15份。
所述甜味剂包括天然甜橙粉0～3份，余量为阿斯巴甜。
原料还包括除甜味剂以外的调味剂、辅料等，还可以包括清茶、纯净水、碳酸饮料或果汁等。
所述原料中维生素C含量为1.5份，维生素B6、维生素D和维生素E的总含量不超过0.5份。
所述原料中牛磺酸含量为2份、柠檬酸含量为3.3份。
本发明所添加物质的功能效果如下：
维生素B6参与近百种酶反应。参与某些神经介质、核酸和DNA合成，有利于维持适宜的免疫功能。
维生素D 能提高肌体对钙、磷的吸收，使血浆钙和血浆磷的水平达到饱和程度；维持血液中柠檬酸盐的正常水平；防止氨基酸通过肾脏损失；促进生长和骨骼钙化，促进牙齿健全。相关研究表明，运动型人群在运动后维生素D的低于普通人体的平均值，更需要在运动后补充维生素D 。
维生素E具有全面、高效的抗氧化作用，能保护细胞膜上的多不饱和脂肪酸免受自由基的攻击，维持细胞膜的完整性，人体在运动时，呼吸、新陈代谢等过程加快，发生氧化作用，产生大量自由基，若自由基产生过量，则会破坏健康的细胞，加速机体的衰老进程并诱发癌症、心脑血管疾病等。维生素E能有效清除体内的自由基，减少维生素A及多元不饱和脂肪酸的氧化、控制细胞氧化、促进伤口的愈合、抑制皮肤晒伤反应，保护细胞膜、皮肤、血管、心脏、眼睛、肝脏及乳房等组织，减少罹患动脉硬化等疾病的机率。
牛磺酸能明显促进神经系统的生长发育和细胞增殖、分化，提高神经传导和视觉机能，保持人体正常血压对心肌细胞有保护作用，同时能促进垂体激素分泌，活化胰腺功能，改善机体内分泌系统的状态，给机体代谢以有益的调节；并具有促进有机免疫力的增强和抗疲劳的作用。
采用上述技术方案所产生的有益效果在于：本发明饮品组合物能够补充能量、提高精力、抗衰老、抗疲劳，由维生素类、微量元素、添加剂类等成分构成，门冬氨酸镁能够提供人体必需的镁元素；维生素类水溶性好，人体易吸收，与门冬氨酸镁合用具有良好的协同作用；是一种用于调节人体机能的功能性饮品制剂；适合旅游爱好者、运动员、体力劳动和脑力劳动者饮用。
具体实施方式
实施例1
一种含维生素C的固体饮品，原料按重量份由以下物质组成：维生素C 1.5份、维生素B6 0.2份、维生素D 0.1份、维生素E 0.2份、门冬氨酸镁0.2份、柠檬酸3.3份、牛磺酸2份、酒石酸22份、碳酸钠2.2份、碳酸氢钠20份、乳糖22份、甘露醇19份、天然甜橙粉2.3份、阿斯巴甜2份、聚乙二醇6000为1份、乙醇1份。
将维生素C、维生素B6、维生素D、维生素E、门冬氨酸镁、柠檬酸、牛磺酸、酒石酸与天然甜橙粉相应份量在双锥混合机内混合均匀，并标注酸粉。将碳酸钠、碳酸氢钠、乳糖、阿斯巴甜、聚乙二醇6000成分按对应的份量在双锥混合机内混合均匀，并标注碱粉，混合均匀后，用自动喷雾器喷洒对应量的乙醇和甘露醇的混合水溶液，喷雾过程中保持双锥转动，喷雾完成后，将酸粉加入碱粉中再次混合，升温至60℃，真空干燥3小时后取样检测水分为0.2%，停止干燥，开始分装至包装袋内。
饮用时根据个人口味取本品3g-5g置于水杯中，加入常温水300毫升，搅拌使其完全溶解即可饮用。与此同时还可以根据个人口味适量添加蔗糖等增加甜度的成分。
实施例2
一种含维生素C的固体饮品，原料按重量份由以下物质组成：维生素C 0.01份、维生素B6 0.01份、维生素D 0.5份、维生素E 0.5份、门冬氨酸镁0.5份、柠檬酸0.01份、牛磺酸1份、碳酸氢钠10份、乳糖41份、天然甜橙粉3份、阿斯巴甜12份、聚乙二醇6000为3份。
按要求将维生素C、维生素B6、维生素D、维生素E、门冬氨酸镁、柠檬酸、牛磺酸与天然甜橙粉相应份量在双锥混合机内混合均匀，并标注酸粉。将碳酸氢钠、乳糖、阿斯巴甜、聚乙二醇6000成分按对应的份量在双锥混合机内混合均匀，并标注碱粉，混合均匀后，用自动喷雾器喷洒重量份为1份的水，喷雾过程中保持双锥转动，喷雾完成后，将酸粉加入碱粉中再次混合，升温真空干燥2.5小时取样检测水分为0.27%，开始分装至包装袋内。
饮用时根据个人口味取本品5g置于水杯中，加入常温水300毫升，搅拌使其完全溶解即可饮用。与此同时还可以根据个人口味适量添加蔗糖等增加甜度的成分。
实施例3
一种含维生素C的固体饮品，原料按重量份由以下物质组成：维生素C 1份、维生素B6 0.5份、维生素D 0.01份、维生素E 0.01份、门冬氨酸镁0.01份、柠檬酸2份、牛磺酸0.01份、酒石酸11份、碳酸钠1.1份、甘露醇41份、阿斯巴甜15份、乙醇3份。
将维生素C、维生素B6、维生素D、维生素E、门冬氨酸镁、柠檬酸、牛磺酸、酒石酸相应份量在双锥混合机内混合均匀，并标注酸粉。将碳酸钠、阿斯巴甜按对应的份量在双锥混合机内混合均匀，并标注碱粉，混合均匀后，用自动喷雾器喷洒对应量的乙醇和甘露醇的混合水溶液，水与乙醇比例为1:3，喷雾过程中保持双锥转动，喷雾完成后，将酸粉加入碱粉中再次混合，升温真空干燥3小时后取样检测水分，当水分≤0.5%时停止混粉，开始分装至包装袋内。
饮用时根据个人口味取本品3g-5g置于水杯中，加入常温水300毫升，搅拌使其完全溶解即可饮用。与此同时还可以根据个人口味适量添加蔗糖等增加甜度的成分。
实施例4
一种含维生素C的固体饮品，原料按重量份由以下物质组成：维生素C 0.5份、维生素B6 0.2份、维生素D 0.1份、维生素E 0.2份、门冬氨酸镁0.2份、柠檬酸3.3份、牛磺酸2份、酒石酸22份、碳酸钠2.2份、碳酸氢钠20份、乳糖25份、甘露醇16份、天然甜橙粉1.5份、聚乙二醇6000为1.5份、乙醇1份。
按要求将维生素C、维生素B6、维生素D、维生素E、门冬氨酸镁、柠檬酸、牛磺酸、酒石酸与天然甜橙粉相应份量在双锥混合机内混合均匀，并标注酸粉。将碳酸钠、碳酸氢钠、乳糖、聚乙二醇6000成分按对应的份量在双锥混合机内混合均匀，并标注碱粉，混合均匀后，用自动喷雾器喷洒对应量的乙醇和甘露醇的混合水溶液，水与乙醇比例为1：1.5，喷雾过程中保持双锥转动，喷雾完成后，将酸粉加入碱粉中再次混合，升温真空干燥3小时后取样检测水分，当水分≤0.5%时停止混粉，开始分装至包装袋内。
饮用时根据个人口味取本品3g-5g置于水杯中，加入常温水300毫升，搅拌使其完全溶解即可饮用。与此同时还可以根据个人口味适量添加蔗糖等增加甜度的成分。
实施例5～10
原料按重量份由以下物质组成，其余参数同实施例1。
Claims (4)
1.一种含有维生素调节剂的固体饮品，其特征在于：原料按重量份由以下物质组成：维生素C 0.01～1.5份、维生素B6 0.01～0.5份、维生素D 0.01～0.5份、维生素E 0.01～0.5份、门冬氨酸镁0.01～0.5份、柠檬酸0.01～3.3份、牛磺酸0.01～2份、酒石酸0～22份、碳酸钠0～2.2份、碳酸氢钠0～20份、乳糖0～41份、甘露醇0～41份、聚乙二醇6000含量0～3份、乙醇0～3份、甜味剂0～15份。
2.根据权利要求１所述的一种含有维生素调节剂的固体饮品，其特征在于：所述甜味剂包括天然甜橙粉0～3份，余量为阿斯巴甜。
3.根据权利要求１所述的一种含有维生素调节剂的固体饮品，其特征在于：原料中所述维生素C含量为1.5份，维生素B6、维生素D和维生素E的总含量不超过0.5份。
4.根据权利要求3所述的一种含有维生素调节剂的固体饮品，其特征在于：原料中所述牛磺酸含量为2份、柠檬酸含量为3.3份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510010749.9A CN104489849B (zh) | 2015-01-09 | 2015-01-09 | 一种含有维生素调节剂的固体饮品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510010749.9A CN104489849B (zh) | 2015-01-09 | 2015-01-09 | 一种含有维生素调节剂的固体饮品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104489849A CN104489849A (zh) | 2015-04-08 |
| CN104489849B true CN104489849B (zh) | 2017-01-04 |
Family
ID=52931382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510010749.9A Active CN104489849B (zh) | 2015-01-09 | 2015-01-09 | 一种含有维生素调节剂的固体饮品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104489849B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106306964A (zh) * | 2016-08-18 | 2017-01-11 | 精晶药业股份有限公司 | 一种含有胍基丁胺的饮片及其制备方法 |
| CN106307533A (zh) * | 2016-08-18 | 2017-01-11 | 精晶药业股份有限公司 | 一种含有胍基丁胺的运动营养补充剂及其制备方法 |
| CN107927511A (zh) * | 2017-12-14 | 2018-04-20 | 苏州维高能生物技术有限公司 | 一种营养均衡的固体饮料 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1173647C (zh) * | 2001-12-17 | 2004-11-03 | 中国人民解放军总后勤部军需装备研究所 | 提神饮料 |
-
2015
- 2015-01-09 CN CN201510010749.9A patent/CN104489849B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104489849A (zh) | 2015-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780119B (zh) | 一种蛹虫草姬松茸药酒及其制备方法 | |
| CN101669629B (zh) | 天然植物型功能保健运动饮料及其制造方法 | |
| CN104522675B (zh) | 抗耐力型疲劳的组合物及其制备方法 | |
| CN106889412A (zh) | 一种提神抗疲劳固体饮料 | |
| CN101502320B (zh) | 一种参姜红枣饮料冲剂的生产方法 | |
| CN1328967C (zh) | 一种茶口含片及其制备方法 | |
| CN104489849B (zh) | 一种含有维生素调节剂的固体饮品 | |
| CN105410854A (zh) | 低钠调味肽盐 | |
| CN106721714A (zh) | 胶原蛋白复合果汁口服液及其制备方法 | |
| CN103622121A (zh) | 一种含丙谷二肽的固体饮品 | |
| CN105368668B (zh) | 酸木瓜酒及其制备方法 | |
| CN101671620A (zh) | 绿龟茶酒及制备方法 | |
| CN102813255B (zh) | 一种功能性保健饮品及其制备方法 | |
| CN101263903A (zh) | 多功能保健饮料 | |
| CN107593971A (zh) | 一种墨米代用茶的制作方法 | |
| CN103877002A (zh) | 酵素酶蛋白排毒祛斑霜 | |
| CN103131608A (zh) | 男人酒饮品及其制备方法 | |
| CN104106826B (zh) | 一种红景天饮料及其制备方法 | |
| CN106509197A (zh) | 一种柠檬乌龙茶的制备方法 | |
| CN100393242C (zh) | 一种延年益寿的保健制剂及其制备方法 | |
| CN107279414A (zh) | 一种复合功能饮料及其制备方法 | |
| CN104306320A (zh) | 一种美白祛脂面膜膏 | |
| RU2422051C1 (ru) | Способ производства кислородных коктейлей | |
| CN109769989A (zh) | 阿胶富硒钙茶及其制备方法 | |
| CN101756224A (zh) | 一种越橘营养饼及其制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |